150 related articles for article (PubMed ID: 11747625)
21. Shared receptor components but distinct complexes for alpha and beta interferons.
Lewerenz M; Mogensen KE; Uzé G
J Mol Biol; 1998 Sep; 282(3):585-99. PubMed ID: 9737924
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms for regulation of cellular responsiveness to human IFN-beta1a.
Dupont SA; Goelz S; Goyal J; Green M
J Interferon Cytokine Res; 2002 Apr; 22(4):491-501. PubMed ID: 12034032
[TBL] [Abstract][Full Text] [Related]
23. Neutralizing epitopes on the extracellular interferon gamma receptor (IFNgammaR) alpha-chain characterized by homolog scanning mutagenesis and X-ray crystal structure of the A6 fab-IFNgammaR1-108 complex.
Sogabe S; Stuart F; Henke C; Bridges A; Williams G; Birch A; Winkler FK; Robinson JA
J Mol Biol; 1997 Nov; 273(4):882-97. PubMed ID: 9367779
[TBL] [Abstract][Full Text] [Related]
24. Domains of interaction between alpha interferon and its receptor components.
Uzé G; Di Marco S; Mouchel-Vielh E; Monneron D; Bandu MT; Horisberger MA; Dorques A; Lutfalla G; Mogensen KE
J Mol Biol; 1994 Oct; 243(2):245-57. PubMed ID: 7932753
[TBL] [Abstract][Full Text] [Related]
25. Structure-function analysis of human IFN-alpha. Mapping of a conformational epitope by homologue scanning.
Wang L; Hertzog PJ; Galanis M; Overall ML; Waine GJ; Linnane AW
J Immunol; 1994 Jan; 152(2):705-15. PubMed ID: 7506733
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of neutralizing efficacy by combining three monoclonal antibodies to human interferon-alpha.
Kontsek P; Borecký L; Novák M; Kontseková E; Máciková I
Immunology; 1991 May; 73(1):8-11. PubMed ID: 1710604
[TBL] [Abstract][Full Text] [Related]
27. Analysis of antigenic domains on natural and recombinant human IFN-beta by the inhibition of biologic activities with monoclonal antibodies.
Redlich PN; Grossberg SE
J Immunol; 1989 Sep; 143(6):1887-93. PubMed ID: 2476486
[TBL] [Abstract][Full Text] [Related]
28. Evidence for glycosphingolipid modification of the type 1 IFN receptor.
Ghislain J; Lingwood CA; Fish EN
J Immunol; 1994 Oct; 153(8):3655-63. PubMed ID: 7930586
[TBL] [Abstract][Full Text] [Related]
29. Homology model of human interferon-alpha 8 and its receptor complex.
Seto MH; Harkins RN; Adler M; Whitlow M; Church WB; Croze E
Protein Sci; 1995 Apr; 4(4):655-70. PubMed ID: 7613464
[TBL] [Abstract][Full Text] [Related]
30. Antibodies that neutralize human beta interferon biologic activity recognize a linear epitope: analysis by synthetic peptide mapping.
Redlich PN; Hoeprich PD; Colby CB; Grossberg SE
Proc Natl Acad Sci U S A; 1991 May; 88(9):4040-4. PubMed ID: 1708891
[TBL] [Abstract][Full Text] [Related]
31. Use of synthetic peptides to identify an N-terminal epitope on mouse gamma interferon that may be involved in function.
Magazine HI; Carter JM; Russell JK; Torres BA; Dunn BM; Johnson HM
Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1237-41. PubMed ID: 2448795
[TBL] [Abstract][Full Text] [Related]
32. Permissive residues within the minimal epitopes of neutralizing monoclonal antibodies to the V3 loop of HIV-1.
Laisney IL; Benjamin H; Gefter M; Strosberg AD
Eur J Immunol; 1996 Jul; 26(7):1634-40. PubMed ID: 8766572
[TBL] [Abstract][Full Text] [Related]
33. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity.
Cajean-Feroldi C; Nosal F; Nardeux PC; Gallet X; Guymarho J; Baychelier F; Sempé P; Tovey MG; Escary JL; Eid P
Biochemistry; 2004 Oct; 43(39):12498-512. PubMed ID: 15449939
[TBL] [Abstract][Full Text] [Related]
34. A monoclonal antibody to recombinant human IFN-alpha receptor inhibits biologic activity of several species of human IFN-alpha, IFN-beta, and IFN-omega. Detection of heterogeneity of the cellular type I IFN receptor.
Benoit P; Maguire D; Plavec I; Kocher H; Tovey M; Meyer F
J Immunol; 1993 Feb; 150(3):707-16. PubMed ID: 8423335
[TBL] [Abstract][Full Text] [Related]
35. Contributions of cloned type I interferon receptor subunits to differential ligand binding.
Cutrone EC; Langer JA
FEBS Lett; 1997 Mar; 404(2-3):197-202. PubMed ID: 9119063
[TBL] [Abstract][Full Text] [Related]
36. Epitope and functional specificity of monoclonal antibodies to mouse interferon-gamma: the synthetic peptide approach.
Russell JK; Hayes MP; Carter JM; Torres BA; Dunn BM; Russell SW; Johnson HM
J Immunol; 1986 May; 136(9):3324-8. PubMed ID: 2420886
[TBL] [Abstract][Full Text] [Related]
37. Human interferon-gamma has three domains associated with its antiviral function: a neutralizing epitope typing scheme for human interferon-gamma.
Kwok AY; Zu X; Yang C; Alfa MJ; Jay FT
Immunology; 1993 May; 79(1):131-7. PubMed ID: 7685313
[TBL] [Abstract][Full Text] [Related]
38. In vitro mutagenesis of HLA-B27. Amino acid substitutions at position 67 disrupt anti-B27 monoclonal antibody binding in direct relation to the size of the substituted side chain.
el-Zaatari FA; Sams KC; Taurog JD
J Immunol; 1990 Feb; 144(4):1512-7. PubMed ID: 1689355
[TBL] [Abstract][Full Text] [Related]
39. Creation of interferon-alpha8 mutants with amino acid substitutions against interferon-alpha receptor-2 binding sites using phage display system and evaluation of their biologic properties.
Yamamoto K; Taniai M; Torigoe K; Yamamoto S; Arai N; Suemoto Y; Yoshida K; Okura T; Mori T; Fujioka N; Tanimoto T; Miyata M; Ariyasu H; Ushio C; Fujii M; Ariyasu T; Ikeda M; Ohta T; Kurimoto M; Fukuda S
J Interferon Cytokine Res; 2009 Mar; 29(3):161-70. PubMed ID: 19196068
[TBL] [Abstract][Full Text] [Related]
40. Immunochemical characterization of antigenic domains on human interferon-beta: spatially distinct epitopes are associated with both antiviral and antiproliferative activities.
Redlich PN; Grossberg SE
Eur J Immunol; 1990 Sep; 20(9):1933-9. PubMed ID: 1698636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
